Search

everythinglearnresearchcommunity

for

Search:↓

Ixekizumab helps improve life quality, physical ability, and work performance in patients with psoriatic arthritis who haven't used biologic drugs before.

RIPK1 inhibitors may help prevent alopecia areata by reducing immune cell activity.

Indinavir, especially with vitamin A, may cause bone changes, but switching to nelfinavir can reduce these effects.

Finasteride helps improve treatment for benign prostatic hyperplasia.

Fisetin may help treat psoriasis and reduce skin inflammation.

Y-27632 helps hair follicle stem cells grow and keep their abilities.

OR101 may effectively treat atopic dermatitis and similar skin conditions.

Oral ritlecitinib and baricitinib are promising treatments for severe alopecia areata due to their balance of effectiveness and safety.

Baricitinib and its combination with lonafarnib improve fat cell formation in certain genetic disorders.

Baricitinib is a promising treatment for alopecia areata.

Sonidegib effectively treated basal cell carcinoma in a patient with lupus without worsening lupus symptoms.

LEKTI is crucial for skin barrier and immune function, affecting conditions like Netherton syndrome and atopic dermatitis.

Sorafenib is effective in treating Desmoid Tumor/Deep Fibromatosis.

Combining oral minoxidil with JAK inhibitors helps regrow hair in severe alopecia areata cases.

Dual-targeting therapies like Janus kinase inhibitors may treat both alopecia areata and other immune diseases.

TGF-β inhibitors may help treat liver fibrosis by targeting various pathways.

No method fully prevents hair loss from chemotherapy, but some methods can reduce it and improve quality of life.

The drug enzalutamide may reduce the ability of the virus causing COVID-19 to enter lung cells.

New inhibitors may reduce gut toxicity from cancer drugs.

Tofacitinib can temporarily improve hair growth in alopecia universalis, but its effectiveness may decrease over time.

CI-1033 causes skin lesions in rats, similar to humans, due to EGF receptor inhibition.

5α-reductase inhibitors may reduce male fertility and could be used for male contraception.

Ritlecitinib is the first FDA-approved pill for treating significant hair loss in alopecia areata patients aged 12 and up.

Systemic immunotherapies are used for immune-related hair loss but not usually for genetic hair loss, unless the patient has both conditions.

Tofacitinib helped a young woman's severe hair loss and arthritis but not her plaque psoriasis.

Baricitinib is effective and safe for treating severe alopecia areata.

Tofacitinib can cause unusual hair growth, requiring careful monitoring and possible laser hair removal.

EETs can delay seizures by affecting GABA activity, offering potential new treatments for seizures.

Interferon therapy is a promising and safe treatment for hepatitis B in Southeast Asia.

Suppressing ODC activity reduces tumor growth in hair follicles.